This week, Professor Chung shares insights on the common misconceptions about the lived experience of Erectile Dysfunction (ED); myths in relation to treatment of ED,

LTR Pharma has today announced it has entered into a Comprehensive Co-Development Agreement with Aptar Pharma for SPONTAN® for global markets. APTAR is a global

LTR Pharma has been featured in The West Australian, in an article titled ‘A Treatment on the Up’ by business journalist Cheyanne Enciso highlighting the

LTR Pharma Executive Chairman, Lee Rodne, recently spoke with Simons Chase of Synthetic.com, taking a deep dive into the Company’s future plans to bring SPONTAN,

LTR Pharma has today announced that SPONTAN® has been prescribed to the first patients under the TGA’s Special Access Scheme (SAS). Patients were prescribed by

Following this week’s announcement of a successful $10.5M capital raise, LTR Pharma’s Executive Chairman, Lee Rodne, spoke with ausbiz about future plans for the commercial